Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Maravai Lifesciences Holdings (MRVI) Leases (2021 - 2025)

Maravai Lifesciences Holdings has reported Leases over the past 5 years, most recently at $64.7 million for Q4 2025.

  • Quarterly results put Leases at $64.7 million for Q4 2025, down 17.63% from a year ago — trailing twelve months through Dec 2025 was $64.7 million (down 17.63% YoY), and the annual figure for FY2025 was $64.7 million, down 17.63%.
  • Leases for Q4 2025 was $64.7 million at Maravai Lifesciences Holdings, down from $78.6 million in the prior quarter.
  • Over the last five years, Leases for MRVI hit a ceiling of $80.6 million in Q2 2023 and a floor of $47.2 million in Q2 2022.
  • Median Leases over the past 5 years was $65.9 million (2023), compared with a mean of $66.1 million.
  • Biggest five-year swings in Leases: surged 70.59% in 2023 and later decreased 17.63% in 2025.
  • Maravai Lifesciences Holdings' Leases stood at $49.1 million in 2021, then skyrocketed by 30.15% to $63.9 million in 2022, then grew by 23.01% to $78.6 million in 2023, then changed by 0.0% to $78.6 million in 2024, then dropped by 17.63% to $64.7 million in 2025.
  • The last three reported values for Leases were $64.7 million (Q4 2025), $78.6 million (Q4 2024), and $78.6 million (Q4 2023) per Business Quant data.